News

Respirana’s ventilators will address the needs of patients with ARDS in ICU and emergency care settings during and after COVID-19.

This is the third major medical association Verana has partnered on large data sets to advance medical research and patient care.

Candesant, CloudCath, GT Medical, Moray Medical, Oncodisc, and Zeto were highlighted.

AI can minimize both false positives and false negatives in diagnosis.

Congratulations to these 13 dynamic, promising startups working to advance healthtech.

The G-Tech patch system sends data to a smartphone app and into a cloud server so that algorithms can process and quantify the motor activity of the digestive organs.

Derek is CEO and founder of Spinal Singularity, a Rosenman Founders Pledge company.

SF-based Arterys, a Rosenman Innovator, is a medical imaging software developer for clinical AI products.

Selected startups will partner with major payors including Echo Health, Express Scripts, and UnitedHealth Group.

Siren’s socks help detect injuries that might otherwise go unnoticed by monitoring the temperature of six regions of the wearer’s foot.

Allotrope’s “StimSite” technology helps surgeons rapidly and safely identify critical tissue structures, like the ureter, during surgery.

Montefiore will implement Siris’s InsightRT software platform to offer clinical decision support and provide insight into patient-specific treatment outcomes prior to initiating treatment.

They will explore the feasibility of integrating Blumio’s sensor into Roche’s next-generation diagnostics device.

During BIO Digital Week, Start-Up Stadium provides an interactive experience where key stakeholders of the early-stage life science community judge startup pitches.

The product addresses a primary failure point of traditional mesh used in hernia surgery.

The funds will support bringing this technology into clinical practice to validate its efficacy and benefit to patients.

An interview with Michael Seres, Founder and CEO, 11 Health.

Florence Nightingale and her revolutionary use of data has more in common with future nursing than you might think.

Top hospital adopting InsightRT platform for innovative approach to integrating historical clinical insights into patient-specific decision making.

With some simple modifications, consumer devices used to treat sleep apnea could be converted into life-saving ventilators for patients with COVID-19.

The Aluna platform was designed from the ground up by a team of asthmatics and healthcare providers to help patients.

DotLab published recently in the American Journal of Obstetrics & Gynecology.

CipherBio publishes a comparative analysis of the top life science accelerators.

Zeto is commercializing a wireless dry-electrode headset for EEGs.

“These 15 companies embody the drive to make a significant difference in people’s lives, by any technological means at their disposal.”

The collaboration is aimed at fundamentally improving the control and accuracy of minimally invasive interventional medical procedures.

The funding will speed commercialization, pending FDA approval, and support R&D for remote infection monitoring applications.

Verana plans further expansions into imaging, genomic, and claims data.

Patients with newly diagnosed malignant brain tumors are now eligible for surgically targeted radiation therapy.

Velano’s PIVO device allows practitioners to collect as much blood as needed while the patient is in the hospital without additional needle sticks.

Raydiant is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth.

Raydiant Oximetry Sensing Systems is a novel, non-invasive technology that more accurately detects fetal distress during labor and delivery.

Encellin is a 2016 Rosenman Innovator and Founders Pledge company.

Early-stage health tech companies chosen for their innovative technology and high growth potential.

The proprietary DotEndo test combines information from a set of new disease biomarkers with machine learning algorithms.

The company was awarded over $3.6 million by the U.S. Army Medical Research and Material Command.

Enspectra met the lead investor for its recent Series A round last year in the Rosenman Innovators program.

The company’s technology is a minimally invasive approach toward treating anal fistula.

The competition was hosted by the UCSF-Stanford Pediatric Device Consortium.

The two companies will develop inhaled nitric oxide technology to treat pulmonary arterial hypertension.

CureMetrix cmTriage is a workflow optimization tool that enables a radiologist to customize, sort, and prioritize their mammography worklist.

Luma’s Illuvinate system is an in-home treatment for psoriasis.

GammaTile™ Therapy is an FDA-cleared, surgically targeted radiation therapy for patients with recurrent brain tumors.

The FDA-cleared treatment is based on proven techniques and designed for lasting remission.

The funds will accelerate development and enable Cenofex to complete early clinical trials.

Catalia is developing Mabu, a personal health assistant robot.

Green Sun’s dynamic brace applies continuous corrective pressure to the spine of adolescent patients with scoliosis.

Funds from the Employment Achievement Award from the Triumph Foundation will offset clinical trial costs.

The company has developed a better fetal monitor to improve outcomes for mothers and babies during childbirth.

The new standard of care will reduce anxiety and risks for hospitalized patients.

Patients undergoing surgery for recurrent brain tumors will benefit from GT Medical’s GammaTile™ Therapy, which helps prevent additional tumor recurrence.

Perceptive is developing minimally-invasive, needle-guided solutions for safe and cost-effective interventional procedures in the areas of cardiology, interventional radiology, interventional oncology and emergency medicine.

Zeto’s “dry electrode” headset, the first of its kind to obtain FDA approval, enables doctors to obtain EEGs quickly and conveniently to 10-20 EEG specifications.

The extra funding gives the company a longer runway to develop its AI software for radiation therapy.

Siren recently unveiled its first product and announced a $3.4M funding round that will help them commercialize other products.

Zenflow’s solution is a device to prop open the urethra, thereby mitigating the symptoms of BPH without the need for surgery or medications.

The Menlo Park-based startup is developing implantable technology for integrated remote patient monitoring, together with a cloud solution.

Arterys unveiled the MICA platform in Chicago at the Radiological Society of North America annual meeting.

Arterys will expand its web-based AI platform, launch several products, and accelerate its cardiac offering.

Catalia can roll out their platform to patients and expand their AI platform into new disease states.

Green Sun, which is developing a tension corset to correct spinal deformity in children, won one of four top cash prizes at the Pedatric Device Innovation Symposium in San Jose.